“anti-TNF drugs”的搜索结果，显示 441-450 项，共有 6874 项

1. 神经科- 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

2. 外科 - 临床试验- 妙佑医疗国际

   ... anti-cancer treatment and have a positive 68Ga-PSMA-11 PET scan. The purpose of this study is to learn if the study drug, [225Ac]Ac-PSMA-R2, is safe and ...

3. 血液科- 临床试验- 妙佑医疗国际

   Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... treatment of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti ...

5. 血液科- 临床试验- 妙佑医疗国际

   Lymphoma is a diversified disease with outcomes differing upon the types and subtypes of lymphoma as well as treatment modalities used. Fertility outcomes ...

6. 放射科- 临床试验- 妙佑医疗国际

   Radioactive drugs, such as lutetium Lu 177 dotatate, may carry radiation directly to tumor cells and may reduce harm to normal cells. Lutetium Lu 177 ...

7. 关于 - 妙佑医疗国际

   High-intensity focused ultrasound also may be used to deliver chemotherapy medicines for some cancers. HIFU is given in an outpatient setting. Because HIFU is ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard of care treatment) ...

9. 肺科- 临床试验- 妙佑医疗国际

   Treatment for FSGS is considered unsuccessful if the patient is unresponsive to standard therapy (e.g., at least 8 weeks of corticosteroids) and fails to ...

10. 神经科- 临床试验- 妙佑医疗国际

    To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...